Rasmus S. Pedersen

1.5k total citations
35 papers, 1.1k citations indexed

About

Rasmus S. Pedersen is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Rasmus S. Pedersen has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 9 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Rasmus S. Pedersen's work include Pharmacogenetics and Drug Metabolism (17 papers), Veterinary Pharmacology and Anesthesia (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Rasmus S. Pedersen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Veterinary Pharmacology and Anesthesia (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Rasmus S. Pedersen collaborates with scholars based in Denmark, Sweden and Portugal. Rasmus S. Pedersen's co-authors include Kim Brøsen, Per Damkier, Flemming Nielsen, Magnus Ingelman‐Sundberg, Jessica Mwinyi, Søren H. Sindrup, Thomas P. Enggaard, Leif Bertilsson, R. Michael Baldwin and Erik Eliasson and has published in prestigious journals such as Journal of the American Statistical Association, The Lancet Infectious Diseases and Molecular Pharmacology.

In The Last Decade

Rasmus S. Pedersen

34 papers receiving 1.1k citations

Peers

Countries citing papers authored by Rasmus S. Pedersen

Since Specialization

Citations

This map shows the geographic impact of Rasmus S. Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasmus S. Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasmus S. Pedersen more than expected).

Fields of papers citing papers by Rasmus S. Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasmus S. Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasmus S. Pedersen. The network helps show where Rasmus S. Pedersen may publish in the future.

Co-authorship network of co-authors of Rasmus S. Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Rasmus S. Pedersen. A scholar is included among the top collaborators of Rasmus S. Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasmus S. Pedersen. Rasmus S. Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis 2024 ·Biomedicines ·Rasmus S. Pedersen, (unknown), Maria Gabriella Raimondo, Lasse Langholm, Georg Schett, Andreas Ramming, M.A. Karsdal, Nicholas Willumsen	1
2	Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer 2023 ·BMC Cancer ·(unknown), (unknown), Neel I. Nissen, Rasmus S. Pedersen, Mogens K. Boisen, Maria Liljefors, Astrid Z. Johansen, Julia S. Johansen, M.A. Karsdal, Nicholas Willumsen	10
3	Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis 2022 ·Biomolecules ·Rasmus S. Pedersen, Neel I. Nissen, Christina Jensen, (unknown), Tina Manon‐Jensen, Majken Lindholm, Lasse Langholm, (unknown), Lars Nannestad Jørgensen, Carsten Palnæs Hansen, Inna M. Chen, Julia S. Johansen, M.A. Karsdal, Nicholas Willumsen	7
4	Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial 2017 ·The Lancet Infectious Diseases ·Luis Rivera, Rasmus S. Pedersen, (unknown), (unknown), Lars Vibe Andreasen, Ingrid Kromann, (unknown), (unknown), Jes Dietrich, Ananda S Bandyopadhyay, Birgit Thierry-Carstensen	9
5	A twin study of the trough plasma steady-state concentration of metformin 2015 ·Pharmacogenetics and Genomics ·Tore Bjerregaard Stage, Per Damkier, Rasmus S. Pedersen, Mette Marie Hougaard Christensen, Lene Christiansen, Kaare Christensen, Kim Brøsen	18
6	Tramadol and O-Desmethyl Tramadol Clearance Maturation and Disposition in Humans: A Pooled Pharmacokinetic Study 2014 ·Clinical Pharmacokinetics ·Karel Allegaert, Nicholas H. G. Holford, Brian J. Anderson, (unknown), Frank Stüber, A. Rochette, Iñaki F. Trocóniz, Horst Beier, Jan de Hoon, Rasmus S. Pedersen, Ulrike M. Stamer	32
7	A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers 2013 ·European Journal of Clinical Pharmacology ·Rasmus S. Pedersen, Per Damkier, Mette Marie Hougaard Christensen, Kim Brøsen	11
8	Multipass haemodialysis: a novel dialysis modality 2012 ·Nephrology Dialysis Transplantation ·James Heaf, M. Axelsen, Rasmus S. Pedersen	8
9	Impact of CYP2C83 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer 2010 ·The Pharmacogenomics Journal* ·Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen, Mansoor Raza Mirza, Rasmus S. Pedersen, Flemming Nielsen, (unknown), (unknown), Nina Keldsen, Per Damkier, Lena E. Friberg, C. Peterson, Werner Vach, Mats O. Karlsson, Kim Brøsen	78
10	Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol’s O-demethylation via CYP2D6 2010 ·European Journal of Clinical Pharmacology ·(unknown), Rasmus S. Pedersen, (unknown), Per Damkier, Kim Brøsen	16
11	Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism 2010 ·Molecular Pharmacology ·Jessica Mwinyi, Isa Cavaco, Rasmus S. Pedersen, Anna Persson, (unknown), Souren Mkrtchian, Magnus Ingelman‐Sundberg	52
12	The transcription factor GATA-4 regulates cytochrome P4502C19 gene expression 2010 ·Life Sciences ·Jessica Mwinyi, Yvonne Hofmann, Rasmus S. Pedersen, Jana Nekvindová, Isa Cavaco, Souren Mkrtchian, Magnus Ingelman‐Sundberg	24
13	New Insights into the Regulation of CYP2C9 Gene Expression: The Role of the Transcription Factor GATA-4 2009 ·Drug Metabolism and Disposition ·Jessica Mwinyi, Jana Nekvindová, Isa Cavaco, Yvonne Hofmann, Rasmus S. Pedersen, Ellie Landman, Souren Mkrtchian, Magnus Ingelman‐Sundberg	16
14	The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism 2009 ·Basic & Clinical Pharmacology & Toxicology ·Stine T. Zwisler, Thomas P. Enggaard, (unknown), Rasmus S. Pedersen, Søren Mikkelsen, Flemming Nielsen, Kim Brøsen, Søren H. Sindrup	83
15	Modelling the pharmacokinetics of tramadol: On the difference between CYP2D6 extensive and poor metabolizers 2008 ·Journal of Theoretical Biology ·Francesca Di Patti, Duccio Fanelli, Rasmus S. Pedersen, (unknown), Francesca Torricelli	7
16	Increased omeprazole metabolism in carriers of the CYP2C1917* allele; a pharmacokinetic study in healthy volunteers 2008 ·British Journal of Clinical Pharmacology ·R. Michael Baldwin, (unknown), Rasmus S. Pedersen, Jessica Mwinyi, Magnus Ingelman‐Sundberg, Erik Eliasson, Leif Bertilsson	119
17	Kinetics of omeprazole and escitalopram in relation to the CYP2C1917 allele in healthy subjects 2008 ·European Journal of Clinical Pharmacology* ·Staffan Rosenborg, Jessica Mwinyi, Maria Andersson, R. Michael Baldwin, Rasmus S. Pedersen, Sarah C. Sim, Leif Bertilsson, Magnus Ingelman‐Sundberg, Erik Eliasson	53
18	Enhanced Sodium Retention After Acute Nitric Oxide Blockade in Mildly Sodium Loaded Patients With Essential Hypertension 2007 ·American Journal of Hypertension ·Jesper Nørgaard Bech, Eva Møller Nielsen, Rasmus S. Pedersen, Kristina B. Svendsen, E. B. Pedersen	12
19	The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers 2006 ·European Journal of Clinical Pharmacology ·(unknown), Per Damkier, (unknown), Rasmus S. Pedersen, Flemming Nielsen, Kim Brøsen	20
20	Tramadol as a new probe for cytochrome P450 2D6 phenotyping: A population study 2005 ·Clinical Pharmacology & Therapeutics ·Rasmus S. Pedersen, Per Damkier, Kim Brøsen	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact